JOSÉ ÁNGEL
GARCÍA SÁENZ
Profesor asociado de Ciencias de la Salud
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (21)
2024
-
Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study
Breast Cancer Research and Treatment, Vol. 203, Núm. 1, pp. 163-172
-
Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management
Clinical and Translational Oncology
2023
-
Editorial: Exercise, physical therapy, and wellbeing in breast cancer patients
Frontiers in Oncology
2022
-
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 6, pp. 1107-1116
-
Treatment with Adjuvant Abemaciclib Plus Endocrine Therapy in Patients with High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical Trial
JAMA Oncology, Vol. 8, Núm. 8, pp. 1190-1194
2021
-
Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
Scientific Reports, Vol. 11, Núm. 1
2020
-
Serum phospholipids fatty acids and breast cancer risk by pathological subtype
Nutrients, Vol. 12, Núm. 10, pp. 1-18
2019
2018
-
Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann's refined classification
Clinical Cancer Research, Vol. 24, Núm. 8, pp. 1845-1852
2017
-
Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer
Breast Cancer Research and Treatment, Vol. 162, Núm. 1, pp. 181-189
2016
-
A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients with Unresectable Squamous Cell Carcinoma of the Head and Neck
International Journal of Radiation Oncology Biology Physics, Vol. 94, Núm. 2, pp. 289-296
2014
-
18F-FDG PET-CT imaging in the neoadjuvant setting for stages II-III breast cancer: Association of loco-regional SUVmax with classical prognostic factors
Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 58, Núm. 1, pp. 66-73
-
Assignment of tumor subtype by genomic testing and pathologic-based approximations: Implications on patient's management and therapy selection
Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 386-394
2013
-
Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients
Annals of Oncology, Vol. 24, Núm. 3, pp. 655-661
2012
-
Erlotinib and chemoradiation in patients with surgically resected locally advanced squamous cell carcinoma of the head and neck: A GICOR phase I trial
Annals of Oncology, Vol. 23, Núm. 4, pp. 1005-1009
-
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial
Cancer, Vol. 118, Núm. 1, pp. 241-247
-
Glutathione S-transferase P1 c.313a > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients
Annals of Oncology, Vol. 23, Núm. 7, pp. 1750-1756
-
Prospective transGEICAM study of the impact of the 21-gene recurrence score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer
Annals of Oncology, Vol. 23, Núm. 3, pp. 625-631
2011
-
A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome
Clinical Cancer Research, Vol. 17, Núm. 7, pp. 2006-2013
-
Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer
Breast Cancer Research and Treatment, Vol. 128, Núm. 1, pp. 127-136